Oct 30, 2020 / NTS GMT
Presentation
Oct 30, 2020 / NTS GMT
=====================
Corporate Participants
=====================
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director
* Mike Kitagawa
Astellas Pharma Inc. - Senior VP of Development Project Management
* Naoki Okamura
Astellas Pharma Inc. - Executive VP, CFO & Representative Director
* Yukio Matsui
Astellas Pharma Inc. - Chief Commercial Officer & Senior Corporate Executive
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Yo Mizuno
Tokio Marine Asset
Astellas Pharma Inc
(OTCPK:ALPMF)
$
11.1275
0 (0%)
Market Cap: 20.04 Bil
Enterprise Value: 23.95 Bil
PE Ratio: 56.39
PB Ratio: 2.01
GF Score: 87/100 Q2 2021 Astellas Pharma Inc Earnings Presentation Transcript
Oct 30, 2020 / NTS GMT
Release Date Price:
$13.73
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers